ATE418969T1 - Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung - Google Patents
Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzungInfo
- Publication number
- ATE418969T1 ATE418969T1 AT06779688T AT06779688T ATE418969T1 AT E418969 T1 ATE418969 T1 AT E418969T1 AT 06779688 T AT06779688 T AT 06779688T AT 06779688 T AT06779688 T AT 06779688T AT E418969 T1 ATE418969 T1 AT E418969T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- controlled release
- release pharmaceutical
- composition containing
- containing carvedilol
- Prior art date
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004195 carvedilol Drugs 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 3
- 239000002702 enteric coating Substances 0.000 abstract 2
- 238000009505 enteric coating Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0500803A HU227490B1 (en) | 2005-08-26 | 2005-08-26 | Sustained release pharmaceutical preparation containing carvedilol |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE418969T1 true ATE418969T1 (de) | 2009-01-15 |
Family
ID=89986232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06779688T ATE418969T1 (de) | 2005-08-26 | 2006-08-23 | Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1928431B8 (de) |
AT (1) | ATE418969T1 (de) |
DE (1) | DE602006004610D1 (de) |
DK (1) | DK1928431T3 (de) |
EA (1) | EA013058B1 (de) |
ES (1) | ES2321980T3 (de) |
HU (1) | HU227490B1 (de) |
NO (1) | NO20081481L (de) |
PL (1) | PL1928431T3 (de) |
PT (1) | PT1928431E (de) |
WO (1) | WO2007023325A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
JP2009513604A (ja) | 2005-10-29 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体 |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
KR20090042967A (ko) | 2006-08-14 | 2009-05-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 플리반세린 제형 및 이의 제조방법 |
AU2007287639A1 (en) * | 2006-08-25 | 2008-02-28 | Boehringer Ingelheim International Gmbh | Controlled release system and method for manufacturing the same |
HU227881B1 (en) * | 2007-02-23 | 2012-05-29 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Sustained release pharmaceutical preparation containing carvedilol |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
CA2699227C (en) | 2007-09-21 | 2014-12-02 | Evonik Roehm Gmbh | Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
WO2009047800A2 (en) * | 2007-10-09 | 2009-04-16 | Lupin Limited | Oral controlled release composition of carvedilol |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
CN103099793B (zh) * | 2013-02-06 | 2015-07-15 | 中国人民解放军第二军医大学 | 片剂及其制备方法 |
JP7336187B2 (ja) * | 2017-11-30 | 2023-08-31 | 日本ケミファ株式会社 | 多層構造を有する粒子状医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2426811A1 (en) * | 2000-10-24 | 2002-08-29 | Smithkline Beecham Corporation | Novel formulations of carvedilol |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
AU2003288608A1 (en) * | 2002-12-20 | 2004-07-14 | Ranbaxy Laboratories Limited | Controlled release, multiple unit drug delivery systems |
-
2005
- 2005-08-26 HU HU0500803A patent/HU227490B1/hu not_active IP Right Cessation
-
2006
- 2006-08-23 DK DK06779688T patent/DK1928431T3/da active
- 2006-08-23 ES ES06779688T patent/ES2321980T3/es active Active
- 2006-08-23 DE DE602006004610T patent/DE602006004610D1/de not_active Expired - Fee Related
- 2006-08-23 EA EA200800666A patent/EA013058B1/ru not_active IP Right Cessation
- 2006-08-23 PL PL06779688T patent/PL1928431T3/pl unknown
- 2006-08-23 PT PT06779688T patent/PT1928431E/pt unknown
- 2006-08-23 AT AT06779688T patent/ATE418969T1/de active
- 2006-08-23 WO PCT/HU2006/000068 patent/WO2007023325A2/en active Application Filing
- 2006-08-23 EP EP06779688A patent/EP1928431B8/de active Active
-
2008
- 2008-03-26 NO NO20081481A patent/NO20081481L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1928431A2 (de) | 2008-06-11 |
PL1928431T3 (pl) | 2009-07-31 |
DE602006004610D1 (de) | 2009-02-12 |
EP1928431B1 (de) | 2008-12-31 |
ES2321980T3 (es) | 2009-06-15 |
EP1928431B8 (de) | 2009-04-08 |
HU227490B1 (en) | 2011-07-28 |
HUP0500803A2 (en) | 2007-05-29 |
HUP0500803A3 (en) | 2008-03-28 |
NO20081481L (no) | 2008-05-19 |
DK1928431T3 (da) | 2009-04-20 |
HU0500803D0 (en) | 2005-11-28 |
PT1928431E (pt) | 2009-03-25 |
WO2007023325A2 (en) | 2007-03-01 |
EA013058B1 (ru) | 2010-02-26 |
WO2007023325A3 (en) | 2007-06-28 |
EA200800666A1 (ru) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE418969T1 (de) | Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung | |
WO2009059701A3 (de) | Retardtabletten mit hydromorphon | |
IL181117A0 (en) | Sustained drug release composition demonstrating an ascending zero order release pattern, methods of manufacturing such a composition | |
WO2007041367A3 (en) | Oral composition containing a salivation inducing agent | |
RS54929B1 (sr) | Formulacija i metod obložene tablete | |
WO2009113703A3 (en) | Orally-disintegrating solid preparation | |
TR201902233T4 (tr) | Hızlı çözünen katı dozaj formu. | |
DE502005009109D1 (de) | Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung | |
WO2009009628A3 (en) | Endoprosthesis coating | |
WO2011060256A3 (en) | Bilayer tablet formulations | |
WO2010053337A3 (ko) | 서방성 미립자 및 이의 제조방법 | |
WO2007149801A3 (en) | Enteric coated particles containing an active ingredient | |
MX2010003304A (es) | Suplemento alimenticio granular. | |
EP2368546A4 (de) | Pharmazeutische zusammensetzung für die gesteuerte freisetzung von methylphenidat | |
MX339587B (es) | Pelicula que se puede rotular con laser resistente al calor. | |
MX2010007577A (es) | Preparacion nutriceutica o farmaceutica revestida con una sustancia activa mejorada liberada en el colon. | |
EP1988138A4 (de) | Beschichtungszusammensetzung, gehärteter film und harzlaminat | |
WO2011101866A3 (en) | Gastric retention formulation containing baclofen | |
MX280211B (es) | Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo. | |
WO2008139136A3 (en) | Sensor coating | |
WO2010022132A3 (en) | Biocompatible coatings, and methods of making and using the same | |
TR201819108T4 (tr) | Kontrollü salımlı matrisli farmasötik dozaj formülasyonu. | |
WO2012091408A3 (en) | Matrix type antimicrobial vehicle and manufacturing method thereof | |
WO2009023761A3 (en) | Pharmaceutical compositions comprising ropinirole | |
DK1728624T3 (da) | Flerlagsfolier med optiske specialeffekter og fremgangsmåder til deres fremstilling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1928431 Country of ref document: EP |